SOL-1 superiority trial continues to demonstrate outstanding patient retention and protocol adherence, with no new or unexpected safety signals ...

VDE Americas' David Devir looks at the origins of the supersized PV glass problem and considers how the industry can return to reliability.

Accuray Incorporated ( NASDAQ: ARAY) Shareholder/Analyst Call September 29, 2025 4:30 PM EDT ...

Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, will host an Investor Day today where it will highlight ...

Think of it as your coding command center—intelligent, streamlined, affordable enough for side-hustlers, indie devs, or curious tinkerers.